Search Results - "Cubiró, X."

Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases by Galván Casas, C., Català, A., Carretero Hernández, G., Rodríguez‐Jiménez, P., Fernández‐Nieto, D., Rodríguez‐Villa Lario, A., Navarro Fernández, I., Ruiz‐Villaverde, R., Falkenhain‐López, D., Llamas Velasco, M., García‐Gavín, J., Baniandrés, O., González‐Cruz, C., Morillas‐Lahuerta, V., Cubiró, X., Figueras Nart, I., Selda‐Enriquez, G., Romaní, J., Fustà‐Novell, X., Melian‐Olivera, A., Roncero Riesco, M., Burgos‐Blasco, P., Sola Ortigosa, J., Feito Rodriguez, M., García‐Doval, I.

“…Summary Background The cutaneous manifestations of COVID‐19 disease are poorly characterized. Objectives To describe the cutaneous manifestations of COVID‐19…”
Get full text

Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses by Garcia-Melendo, C, Cubiró, X, Puig, L

“…Dermatologists' interest in the Janus-associated kinase (JAK)/signal transducers and activators of transcription (STAT) pathway has been growing as evidence…”
Get full text

Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria by Curto‐Barredo, L., Spertino, J., Figueras‐Nart, I., Expósito‐Serrano, V., Guilabert, A., Melé‐Ninot, G., Cubiró, X., Bonfill‐Ortí, M., Garcias‐Ladaria, J., Villar, M., García‐Navarro, X., Bielsa‐Marsol, I., Vilavella, M., Aparicio, G., Baliu‐Piqué, C., Álvarez, A., Lamas‐Domenech, N., Duran‐Jordà, X., Serra‐Baldrich, E., Giménez‐Arnau, A.

Get full text

Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomized Controlled Study With Quality-of-Life Evaluation by Cubiró, X., Garcia-Melendo, C., Morales-Munera, C.E., Riera-Mestre, A., Torres-Iglesias, R., Villanueva, B., Puig, L., Baselga, E.

“…Hereditary haemorrhagic telangiectasia (HHT) is characterized by the presence of telangiectases and larger arteriovenous malformations in different organs…”
Get full text

Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses by Garcia-Melendo, C., Cubiró, X., Puig, L.

“…Dermatologists’ interest in the Janus-associated kinase (JAK)/signal transducers and activators of transcription (STAT) pathway has been growing as evidence…”
Get full text

The Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months’ Evolution and Prior Immunosuppressive Treatment by Cubiró, X., Spertino, J., Rozas-Muñoz, E., Serra-Baldrich, E., Puig, L.

“…The efficacy of omalizumab in the treatment of chronic spontaneous urticaria has been demonstrated in phase iii clinical trials, but limited information is…”
Get full text

Janus Kinase Inhibitors in Dermatology: Part 1 - General Considerations and Applications in Vitiligo and Alopecia Areata by Garcia-Melendo, C, Cubiró, X, Puig, L

“…Dermatologists' interest in the Janus-associated kinase/signal transducers and activators of transcription (JAK/STAT) pathway has been growing as evidence…”
Get full text

Saprochaete capitata disseminated infection presenting as macular rash after haematopoietic stem cell transplantation by Garcia‐Melendo, C., Cubiró, X., López‐Sánchez, C., Turienzo, M., Mozos, A., Puig, L.

Get full text

Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomized Controlled Study With Quality-of-Life Evaluation by Cubiró, X, Garcia-Melendo, C, Morales-Munera, C E, Riera-Mestre, A, Torres-Iglesias, R, Villanueva, B, Puig, L, Baselga, E

“…Hereditary haemorrhagic telangiectasia (HHT) is characterized by the presence of telangiectases and larger arteriovenous malformations in different organs…”
Get full text

The Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months' Evolution and Prior Immunosuppressive Treatment by Cubiró, X, Spertino, J, Rozas-Muñoz, E, Serra-Baldrich, E, Puig, L

“…BACKGROUNDThe efficacy of omalizumab in the treatment of chronic spontaneous urticaria has been demonstrated in phase iii clinical trials, but limited…”
Get full text

Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata by Garcia-Melendo, C., Cubiró, X., Puig, L.

“…Dermatologists’ interest in the Janus-associated kinase/signal transducers and activators of transcription (JAK/STAT) pathway has been growing as evidence…”
Get full text

Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata by C. Garcia-Melendo, X. Cubiró, L. Puig

“…Resumen: La vía de señalización de citocinas Janus cinasa/transductor de señal y activador de transcripción (JAK/STAT) es un área de interés emergente en…”
Get full text

Cutaneous reactions after SARS‐CoV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases by Català, A., Muñoz‐Santos, C., Galván‐Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá‐Truyols, A., Giavedoni, P., Llamas‐Velasco, M., González‐Cruz, C., Cubiró, X., Ruíz‐Villaverde, R., Gómez‐Armayones, S., Gil Mateo, M.P., Pesqué, D., Marcantonio, O., Fernández‐Nieto, D., Romaní, J., Iglesias Pena, N., Carnero Gonzalez, L., Tercedor‐Sanchez, J., Carretero, G., Masat‐Ticó, T., Rodríguez‐Jiménez, P., Gimenez‐Arnau, A.M., Utrera‐Busquets, M., Vargas Laguna, E., Angulo Menéndez, A.G., San Juan Lasser, E., Iglesias‐Sancho, M., Alonso Naranjo, L., Hiltun, I., Cutillas Marco, E., Polimon Olabarrieta, I., Marinero Escobedo, S., García‐Navarro, X., Calderón Gutiérrez, M.J., Baeza‐Hernández, G., Bou Camps, L., Toledo‐Pastrana, T., Guilabert, A.

“…Summary Background Cutaneous reactions after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccines are poorly characterized. Objective To…”
Get full text

[Artículo traducido] Tratamiento comparativo de lesiones mucocutáneas en pacientes con telangiectasia hemorrágica hereditaria con láser dual secuencial de colorante pulsado y neodimio: itrio-aluminio-granate versus neodimio: itrio-aluminio-granate solo: un estudio controlado aleatorizado doble ciego con evaluación de la calidad de vida by X. Cubiró, C. Garcia-Melendo, C.E. Morales-Munera, A. Riera-Mestre, R. Torres-Iglesias, B. Villanueva, L. Puig, E. Baselga

“…Resumen: Antecedentes: La telangiectasia hemorrágica hereditaria (THH) se caracteriza por la presencia de telangiectasias y malformaciones arteriovenosas de…”
Get full text

Inhibidores de JAK: usos en dermatología. Parte 2: aplicaciones en psoriasis, dermatitis atópica y otras dermatosis by García-Melendo, C., Cubiró, X., Puig, L.

“…La vía de señalización de citocinas Janus cinasa/transductor de señal y activador de transcripción (JAK/STAT) es un área de interés emergente en dermatología,…”
Get full text

Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata by Garcia-Melendo, C., Cubiró, X., Puig, L.

“…[Display omitted] La vía de señalización de citocinas Janus cinasa/transductor de señal y activador de transcripción (JAK/STAT) es un área de interés emergente…”
Get full text

[Artículo traducido] Tratamiento comparativo de lesiones mucocutáneas en pacientes con telangiectasia hemorrágica hereditaria con láser dual secuencial de colorante pulsado y neodimio: itrio-aluminio-granate versus neodimio: itrio-aluminio-granate solo: un estudio controlado aleatorizado doble ciego con evaluación de la calidad de vida by Cubiró, X., Garcia-Melendo, C., Morales-Munera, C.E., Riera-Mestre, A., Torres-Iglesias, R., Villanueva, B., Puig, L., Baselga, E.

“…La telangiectasia hemorrágica hereditaria (THH) se caracteriza por la presencia de telangiectasias y malformaciones arteriovenosas de mayor tamaño en…”
Get full text

Exploring the potential of artificial intelligence in improving skin lesion diagnosis in primary care by Escalé-Besa, Anna, Yélamos, Oriol, Vidal-Alaball, Josep, Fuster-Casanovas, Aïna, Miró Catalina, Queralt, Börve, Alexander, Ander-Egg Aguilar, Ricardo, Fustà-Novell, Xavier, Cubiró, Xavier, Rafat, Mireia Esquius, López-Sanchez, Cristina, Marin-Gomez, Francesc X.

“…Dermatological conditions are a relevant health problem. Machine learning (ML) models are increasingly being applied to dermatology as a diagnostic decision…”
Get full text

Expérience du traitement combiné avec laser à colorant pulsé et grenat d’yttrium et aluminium dopé au néodyme chez les patients avec télangiectasie hémorragique héréditaire by Cubiró Raventós, X., Flores Climente, V., Garcia Melendo, C., Puig Sanz, L., Baselga Torres, E.

“…La maladie de Rendu–Osler–Weber ou télangiectasie hémorragique héréditaire (THH) est caractérisée par la présence de multiples télangiectasies…”
Get full text